Er Cao

Er Cao (Herba Hedyotidis Auriculariae) is the dried whole herb of Hedyotis auricularia L. (syn. Oldenlandia auricularia), a small perennial herbaceous plant in the family Rubiaceae (coffee family). In the traditional TCM classification system, Er Cao is considered bitter and slightly sweet in flavor with a cool nature. It enters the Liver, Lung, and Large Intestine meridians, giving it a role in formulas that address heat-toxin accumulation, damp-heat patterns, and traumatic injuries with swelling and bleeding.

Botanical description: Hedyotis auricularia is a small, often prostrate or ascending perennial herb growing 15–40 cm tall. The stems are slender, quadrangular, often purplish, and frequently branched from the base. The leaves are opposite, sessile or shortly petiolate, ovate-lanceolate to oblong-lanceolate, 1.5–4 cm long and 0.5–1.5 cm wide, with an acute apex and a rounded to cuneate base. The leaf surface is glabrous or sparsely hairy, with prominent veins on the lower surface. The stipules are small, triangular, and membranous. The plant produces small, white or pale pink flowers in dense axillary clusters (cymes). The corolla is tubular, with four spreading lobes. The fruit is a small, globose capsule containing numerous tiny seeds. The common name "Er Cao" (Ear Grass) refers to the ear-like shape of the leaves in some forms of this species.

Habitat and distribution: H. auricularia is widely distributed across tropical and subtropical Asia, including southern China (particularly Guangdong, Guangxi, Yunnan, Fujian, and Hainan provinces), India, Sri Lanka, Myanmar, Thailand, Vietnam, Malaysia, Indonesia, and the Philippines. The plant prefers moist, shaded environments and is commonly found in forests, grasslands, along roadsides, and in waste areas at elevations from sea level to 1,500 meters. It thrives in warm, humid climates with well-drained soil. The whole herb is typically harvested in summer and autumn when the plant is in full vegetative growth, then washed, cut into sections, and dried in the sun or shade for medicinal use.

Quality markers: High-quality Er Cao should have intact leaves that are green to dark green, slender stems that are purplish-green, and a characteristic slightly bitter taste. The dried herb should be free from mold, insect damage, and excessive stem material. Unlike some more widely used pharmacopoeial herbs, Er Cao does not have specific quantitative marker compound standards in the Chinese Pharmacopoeia, reflecting its status as a less commonly standardized herb in modern TCM practice. Quality assessment relies primarily on organoleptic evaluation — appearance, color, taste, and aroma.

In the traditional Chinese medicine theoretical framework, Er Cao is understood in terms of its effects on specific patterns of disharmony (zheng). Because Er Cao enters the Liver, Lung, and Large Intestine meridians and has a bitter, slightly sweet, cool quality, it is traditionally indicated for a range of patterns involving heat-toxin, damp-heat, and bleeding disorders.

Clearing heat and resolving toxicity: Er Cao is traditionally used for heat-toxin patterns manifesting as sore throat, furuncles, carbuncles, and various skin infections. In TCM theory, when heat-toxin accumulates in the body, it may present as localized redness, swelling, heat, and pain. Er Cao is believed to clear this pathological heat and resolve the toxin, thereby reducing inflammation and promoting healing. It is often used in combination with other heat-clearing and detoxifying herbs such as Jin Yin Hua and Pu Gong Ying for enhanced effect. This traditional use is based on TCM pattern differentiation and should not be equated to specific dermatological or infectious disease diagnoses.

Treating damp-heat jaundice: Er Cao is traditionally used for damp-heat patterns affecting the Liver and Gallbladder, particularly those presenting as jaundice with yellowing of the skin and sclera, dark urine, and a bitter taste in the mouth. Its bitter-cool nature is believed to drain dampness and clear heat from the Liver and Gallbladder. In traditional practice, it is often combined with Yin Chen Hao and Zhi Zi for treating damp-heat jaundice. These applications are based on traditional TCM theory and should not be interpreted as treatment for specific hepatobiliary diseases.

Reducing swelling and relieving pain: Er Cao is traditionally applied to reduce swelling and relieve pain associated with traumatic injuries, bruises, sprains, and inflammatory swellings. Its ability to clear heat and resolve toxicity is believed to address the localized heat and stagnation that accompanies swelling and pain. It may be used both internally as a decoction and externally as a poultice or wash. For traumatic injuries, it is traditionally combined with blood-invigorating and pain-relieving herbs such as Dan Shen and Ru Xiang.

Stopping bleeding: Er Cao is traditionally used for various bleeding disorders, particularly those attributed to heat in the blood. In TCM theory, when heat enters the blood, it may cause reckless movement of blood leading to hemorrhage. Er Cao is believed to cool the blood and stop bleeding, and it has been traditionally used for conditions such as hemoptysis (coughing up blood), epistaxis (nosebleeds), and hematochezia (blood in the stool). Its astringent properties are also thought to contribute to its hemostatic effects. This traditional use is based on TCM theory and should not be equated to modern medical management of bleeding disorders.

Regional and folk medicine traditions: In various regional traditions across southern China and Southeast Asia, Er Cao has been used for a broader range of conditions, including dysentery, urinary tract discomfort, snake bites, and insect stings. In some traditional systems, the fresh juice of the plant is applied directly to wounds and skin infections. In Ayurvedic medicine, species of the Hedyotis genus have been used for fever, liver disorders, and skin diseases. These regional uses reflect the plant's wide distribution across tropical Asia and its integration into multiple traditional medical systems. However, systematic documentation and clinical validation of these uses are limited.

Er Cao contains a range of bioactive compounds that have been the subject of pharmacological investigation. The following overview summarizes the major chemical constituents identified in the whole herb of Hedyotis auricularia and what is currently known about them from published research.

Triterpenoids: Triterpenoids are among the most characteristic and pharmacologically significant constituents of Er Cao. Ursolic acid and oleanolic acid are the two most abundant pentacyclic triterpenoids identified in this species. These compounds have been studied extensively in pre-clinical research for their anti-inflammatory, hepatoprotective, antitumor, and antimicrobial properties. Ursolic acid has been shown to inhibit inflammatory mediators through modulation of NF-kappaB and COX-2 pathways in in-vitro models. Oleanolic acid has demonstrated hepatoprotective effects in animal models of chemically induced liver injury. Both compounds are widely distributed in the plant kingdom and are not unique to Er Cao, but their presence contributes to the herb's overall pharmacological profile.

Flavonoids: Er Cao contains several flavonoids, including quercetin, kaempferol, and their glycoside derivatives. These compounds are well-known for their antioxidant and anti-inflammatory properties. Quercetin has been studied for its ability to scavenge free radicals, inhibit lipid peroxidation, and modulate inflammatory signaling pathways. Kaempferol and its glycosides have demonstrated anti-inflammatory, antimicrobial, and cardioprotective effects in pre-clinical studies. The flavonoid content of Er Cao may vary significantly depending on growing conditions, harvest time, and post-harvest processing. These compounds are common to many plant species and are not specific biomarkers for Er Cao.

Iridoid glycosides: Iridoid glycosides are characteristic chemical markers of the Rubiaceae family and are present in Er Cao. Compounds such as asperuloside, scandoside, and their derivatives have been identified in this and related Hedyotis species. These compounds have been studied for their anti-inflammatory, analgesic, and hepatoprotective properties in pre-clinical models. Asperuloside has been shown to exhibit anti-inflammatory activity through inhibition of pro-inflammatory cytokine production. Iridoid glycosides are generally considered to contribute to the bitter taste of Er Cao, which in TCM theory is associated with its heat-clearing and dampness-draining properties.

Anthraquinones: Various hydroxyanthraquinone derivatives have been isolated from Er Cao. Anthraquinones are a class of compounds known for their antimicrobial and laxative properties. In pre-clinical studies, anthraquinones from related Hedyotis species have demonstrated antibacterial activity against both Gram-positive and Gram-negative bacteria. The anthraquinone content of Er Cao is generally lower than that of more well-known anthraquinone-containing herbs such as Da Huang (Rheum species). Nevertheless, these compounds may contribute to the herb's traditional use for clearing heat-toxin, particularly in the context of skin infections and dysentery.

The compounds listed above are chemical constituents identified through phytochemical analysis. Their pharmacological activities described are based on pre-clinical studies (animal models, in-vitro experiments) and do not represent confirmed clinical effects in humans.

Unlike more widely recognized herbs, Er Cao does not feature prominently in the major classical formula compendiums of TCM. However, it appears in regional and folk medicine traditions across southern China and Southeast Asia. Below are representative combinations that illustrate how Er Cao is used in traditional practice.

The following section summarizes published pharmacological and pre-clinical research on Hedyotis species. Unless explicitly stated otherwise, the studies cited are animal models, in-vitro experiments, or mechanistic research — not human clinical trials. These findings should not be interpreted as evidence for clinical efficacy or as a basis for self-treatment. Note that much of the available research focuses on the more widely studied Hedyotis diffusa (Bai Hua She She Cao) rather than H. auricularia specifically.

Anti-inflammatory activity of Hedyotis species: Research on Hedyotis species has demonstrated anti-inflammatory effects in various pre-clinical models. The triterpenoids ursolic acid and oleanolic acid, both present in Er Cao, have been shown to inhibit the production of pro-inflammatory mediators including TNF-alpha, IL-1beta, and IL-6 through modulation of the NF-kappaB signaling pathway. These compounds also inhibit cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) expression in activated macrophages. The flavonoid quercetin contributes additional anti-inflammatory activity through antioxidant mechanisms and inhibition of inflammatory enzyme systems. These findings provide mechanistic support for the traditional use of Er Cao as a heat-clearing and anti-inflammatory herb, but they are derived from in-vitro studies and should not be extrapolated to clinical efficacy.

Antimicrobial properties: Extracts of various Hedyotis species, including H. auricularia, have demonstrated antimicrobial activity against a range of bacterial and fungal pathogens in laboratory studies. The anthraquinone and flavonoid fractions have shown inhibitory effects against Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa in agar diffusion and broth dilution assays. The iridoid glycoside fraction has demonstrated more modest antimicrobial activity. Some studies have also investigated the antiviral potential of Hedyotis extracts, particularly against herpes simplex virus and influenza virus in cell culture models. However, the concentrations required for antimicrobial effects in vitro may not be achievable through oral administration in humans, and well-designed clinical trials confirming antimicrobial efficacy are lacking.

Hepatoprotective effects: The triterpenoid constituents of Er Cao, particularly oleanolic acid, have been studied for their hepatoprotective effects in animal models of chemically induced liver injury. Oleanolic acid has been shown to reduce serum transaminase levels (ALT, AST) and attenuate hepatic necrosis in models of carbon tetrachloride (CCl4)-induced hepatotoxicity. The proposed mechanisms include antioxidant activity, inhibition of cytochrome P450-mediated bioactivation of hepatotoxins, and preservation of hepatocellular membrane integrity. These pre-clinical findings are consistent with the traditional use of Er Cao for damp-heat jaundice but do not constitute evidence for clinical efficacy in human liver diseases.

Antioxidant activity: The flavonoids and phenolic compounds in Er Cao exhibit significant antioxidant activity in standard in-vitro assays, including DPPH radical scavenging, ABTS radical cation decolorization, and ferric reducing antioxidant power (FRAP) assays. The flavonoid quercetin and its glycosides are particularly potent antioxidants due to their ability to donate hydrogen atoms and chelate transition metal ions. The triterpenoids also contribute to the overall antioxidant profile, though to a lesser extent. While antioxidant activity is a well-established property of many plant-derived compounds, the clinical significance of dietary or supplemental antioxidants for disease prevention or treatment remains a subject of scientific debate. The translation from in-vitro antioxidant capacity to human health benefits is not straightforward.

What the research does NOT show: Despite the pre-clinical signals described above, the research on Er Cao and related Hedyotis species does NOT demonstrate conclusive clinical efficacy for any specific disease in humans. There is no robust evidence from large-scale, randomized, placebo-controlled clinical trials that Er Cao can treat, cure, or prevent infectious diseases, inflammatory disorders, liver diseases, or any other medical condition. The translation from animal models and in-vitro studies to human clinical relevance is uncertain. Furthermore, most published research on the Hedyotis genus focuses on H. diffusa (Bai Hua She She Cao) rather than H. auricularia, and findings from one species should not be assumed to apply to the other. This page does not endorse Er Cao as a treatment for any condition.

Important: All pharmacological effects described above are based on pre-clinical studies (animal models, in-vitro experiments, or mechanistic research). They do not constitute evidence of clinical efficacy in humans. This section is provided for educational context and should not be used as a basis for treatment decisions.

General safety profile: Er Cao is used in regional TCM and folk medicine traditions, but comprehensive safety data from modern toxicological studies are limited. The information below reflects what is currently known from published literature, traditional clinical experience, and the safety profile of related Hedyotis species. As with all herbal products, Er Cao is not free of risk, and its use should be guided by a qualified healthcare professional.

Spleen-Stomach deficiency-cold: In traditional TCM theory, Er Cao is bitter and cool in nature. Individuals with Spleen-Stomach deficiency-cold patterns — characterized by poor appetite, abdominal distension, loose stools, a pale tongue with white coating, and a slow, weak pulse — should use Er Cao with caution, as its bitter-cold nature may further weaken digestive function. Prolonged use or high doses may exacerbate symptoms such as abdominal discomfort, diarrhea, and fatigue. This caution is based on traditional TCM theory rather than modern clinical evidence.

Qi and Blood deficiency: Er Cao's cooling and dispersing properties may be overly draining for individuals with Qi and Blood deficiency patterns. Symptoms such as fatigue, pallor, dizziness, palpitations, and general weakness may be worsened by the use of bitter-cool herbs. In TCM theory, herbs that clear heat and resolve toxicity are generally used for excess (shi) patterns and are contraindicated or used with extreme caution in deficiency (xu) patterns. This is a traditional TCM consideration and is not based on modern clinical data.

Pregnancy and lactation: There is insufficient safety data to establish the safety of Er Cao during pregnancy and lactation. In traditional TCM theory, bitter-cool herbs that clear heat and cool the blood are generally avoided or used with extreme caution during pregnancy, particularly in the first trimester. The potential effects of Er Cao's anthraquinone and triterpenoid constituents on fetal development have not been studied. Er Cao should be avoided during pregnancy and lactation unless under the direct supervision of a qualified healthcare professional who has carefully assessed the risk-benefit ratio.

Anthraquinone-related concerns: The anthraquinone content of Er Cao, while lower than that of herbs such as Da Huang (Rheum species), may cause gastrointestinal effects including abdominal cramping and diarrhea, particularly at higher doses or with prolonged use. Long-term use of anthraquinone-containing herbs has been associated in some studies with melanosis coli (pigmentation of the colonic mucosa) and electrolyte imbalances. The clinical significance of the anthraquinone content of Er Cao at typical traditional doses has not been established through systematic study.

Drug interactions: There is very limited published data on drug interactions involving Er Cao. Based on its phytochemical profile, several theoretical interactions warrant consideration. The anthraquinone content may potentiate the effects of other laxative medications and may theoretically reduce the absorption of orally administered drugs due to shortened gastrointestinal transit time. The flavonoid constituents may affect hepatic cytochrome P450 enzyme activity, potentially altering the metabolism of drugs processed through these pathways. Given the lack of clinical interaction data specific to Er Cao, consult a qualified healthcare professional before combining it with any prescription medications.

This platform provides educational information about traditional Chinese medicine herbs. It does not recommend, endorse, or prescribe the use of Er Cao or any other herbal product for the treatment of any medical condition. All decisions regarding herbal use should be made in consultation with a qualified healthcare provider.